SABS Competitors & Alternatives
Compare SAB Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
SABS
Main Stock$3.78
Tradestie Score
50
Market Cap
$20.61M
P/E Ratio
16.1
Revenue Growth
-0.6%
Analyst Upside
+207.8%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.92
|
$371.64M | - | 38 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$21.68
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$47.62
|
$353.70M | - | 42 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 42 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.07
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$14.77
|
$328.62M | - | 30 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$17.19
|
$308.74M | - | 48 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$13.13
|
$304.12M | - | 35 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.34
|
$297.23M | - | 47 | Compare |
More SABS Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
242 stocks in this industry